Review
doi: 10.1080/00015458.2007.11680051.
Tamoxifen or aromatase inhibitors in breast cancer: efficacy and safety
Affiliations
- PMID: 17685248
- DOI: 10.1080/00015458.2007.11680051
Item in Clipboard
Review
Tamoxifen or aromatase inhibitors in breast cancer: efficacy and safety
Acta Chir Belg.
2007 Jun.
No abstract available
Similar articles
-
Adjuvant treatment of breast cancer.R I Med. 1995 Sep;78(9):250-3. R I Med. 1995. PMID: 7579720 Review. No abstract available.
-
[Anti-aromatase acting drugs].Krankenpfl J. 2005;43(4-6):150-1. Krankenpfl J. 2005. PMID: 16171094 German. No abstract available.
-
Letrozole in postmenopausal hormone-responsive early-stage breast cancer: a viewpoint by Gerald M. Higa.Drugs. 2006;66(3):363-4. doi: 10.2165/00003495-200666030-00011. Drugs. 2006. PMID: 16526828 No abstract available.
-
Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer.Ann Oncol. 2007 Sep;18 Suppl 8:viii26-35. doi: 10.1093/annonc/mdm263. Ann Oncol. 2007. PMID: 17890211 Review.
-
Letrozole : in postmenopausal hormone-responsive early-stage breast cancer.Drugs. 2006;66(3):353-62. doi: 10.2165/00003495-200666030-00010. Drugs. 2006. PMID: 16526826 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
